Healthcare upgrades, downgrades, and initiations for Tuesday

|By:, SA News Editor

Galena Biopharma (GALE +6.8%initiated at Outperform at Oppenheimer. Price target is $6.

Veracyte (VCYT +7%) started at Outperform at Leerink (PT $17), William Blair, and Cowen (PT $16).

Surgical Care Affiliates (SCAI +2.8%) initiated at Buy at BofA. Price target is $34. Yesterday: Goldman starts SCAI at Neutral.

Heartware (HTWR +2.3%) started at Buy at CRT Capital. Price target is $109.

Mallinckrodt (MNK +2%initiated at Buy at Jefferies. Price target is $60.

Harvard Bioscience (HBIO +4.4%upgraded to Buy from Neutral at Sidoti.

Forest Labs (FRX +1.1%) upgraded to Neutral from Underweight at Piper. Price target hiked to $49 from $33.

Cardiovascular Systems (CSII +0.9%) cut to Hold at Benchmark. Price target is $35.